AR004695A1 - NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE. - Google Patents
NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE.Info
- Publication number
- AR004695A1 AR004695A1 ARP960104916A ARP960104916A AR004695A1 AR 004695 A1 AR004695 A1 AR 004695A1 AR P960104916 A ARP960104916 A AR P960104916A AR P960104916 A ARP960104916 A AR P960104916A AR 004695 A1 AR004695 A1 AR 004695A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- alkenyl
- group
- furyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a compuestos de N-glioxil prolil ester neurotroficos que tienen afinidad con inmunofilinas del tipo FKBP, supreparación y uso como inhibidores de actividad de enzima relacionada con proteinas inmunofilinas,y particularmente inhibidores de actividad de enzimapeptidil-prolil isomerasa o rotamasa. Los compuestos poseen la formula general (I) donde R1 es un grupo de alquilo o alquenilo C1-C9 de cadena recta oramificada opcionalmente sustituido porcicloal quilo C3-C8, cicloalquilo C3 o C5, cicloalquenilo C5-C7, o Ar1 donde los mencionados grupos de alquilo,alquenilo cicloalquilo o cicloalquenilo pueden ser opcionalmente sustituidos por alquilo C1-C4, alquenilo C1-C4, o hidroxi, y dondeAr1 es sel eccionado delgrupo consistente de 1-naftilo, 2-naftilo, 2-indolilo, 3-indolilo, 2-furilo, 3-furilo, 2-tieniloL, 2-,3-, o 4-piridilo, o fenilo, teniendo 1 a 3sustituyentes; X es oxigeno o sulfuro; Y es oxigeno o NR2, donde R2 eshidrogeno o alquilo C1-C6; y Z es alquilo o alquenilo C2-C6 de cadena recta oramificada donde la cadena de alquilo es sustituida en una o mas posiciones por Ar1, segun definido arriba, cicloalquilo C3-C8, cicloalquilo conectado por unacadena dealquilo o alque nilo C1-C6 recta o no ramificada, o Ar2 donde Ar2 es seleccionado del grupo consistente de 2-indolilo, 3-indolilo, 2-furilo,3-furilo 2-tiazolilo, 2-tienilo, 3-tienilo, 2-, 3- o 4- piridilo, o fenilo, teniendo uno a tressustituyentes; Z también puede ser el fragmento (II) dondeR3 es seleccionado del grupo consistente de alquilo recto o ramificado C1-C8 opcionalmente sustituido por cicloalquilo C3-C8, o Ar1, conforme lo definidoarriba; X2 es ONR5,donde R5 esseleccionado del grupo consis tente en hidrogeno, alquilo y alquenilo C1-C6 recto o ramificado; R4 es seleccionado del grupoThe present invention relates to neurotrophic N-glyoxil prolyl ester compounds having affinity for FKBP-type immunophilins, their use and suppression as inhibitors of enzyme activity related to immunophilin proteins, and particularly inhibitors of enzyme activity peptidyl prolyl isomerase or rotamase. The compounds have the general formula (I) where R1 is a branched straight chain C1-C9 alkyl or alkenyl group optionally substituted by C3-C8 cycloalkyl, C3 or C5 cycloalkyl, C5-C7 cycloalkenyl, or Ar1 where said groups of alkyl, alkenyl, cycloalkyl or cycloalkenyl may optionally be substituted by C1-C4 alkyl, C1-C4 alkenyl, or hydroxy, and where Ar1 is selected from the group consisting of 1-naphthyl, 2-naphthyl, 2-indolyl, 2- furyl, 3-furyl, 2-thienylL, 2-, 3-, or 4-pyridyl, or phenyl, having 1 to 3 substituents; X is oxygen or sulfide; Y is oxygen or NR2, where R2 is hydrogen or C1-C6 alkyl; and Z is straight-chain oramified C2-C6 alkyl or alkenyl where the alkyl chain is substituted at one or more positions by Ar1, as defined above, C3-C8 cycloalkyl, cycloalkyl connected by a straight chain or C1-C6 alkenyl or unbranched, or Ar2 where Ar2 is selected from the group consisting of 2-indolyl, 3-indolyl, 2-furyl, 3-furyl 2-thiazolyl, 2-thienyl, 3-thienyl, 2-, 3- or 4- pyridyl, or phenyl, having one of three substituents; Z may also be fragment (II) where R3 is selected from the group consisting of C1-C8 straight or branched alkyl optionally substituted by C3-C8 cycloalkyl, or Ar1, as defined above; X2 is ONR5, where R5 is selected from the group consisting of hydrogen, C1-C6 straight or branched alkyl and alkenyl; R4 is selected from the group
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/650,461 US5859031A (en) | 1995-06-07 | 1996-05-21 | Small molecule inhibitors of rotamase enzyme activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004695A1 true AR004695A1 (en) | 1999-03-10 |
Family
ID=24609008
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960104916A AR004695A1 (en) | 1996-05-21 | 1996-10-25 | NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE. |
ARP010104365A AR030740A2 (en) | 1996-05-21 | 2001-09-14 | A COMPOUND DERIVED FROM N-GLIOXYLPROLINE AND A METHOD TO PREPARE IT |
ARP010104364A AR030739A2 (en) | 1996-05-21 | 2001-09-14 | A NON-IMMUNOSUPRESSIVE COMPOUND DERIVED FROM N-GLIOXYLPROLINE, A METHOD TO PREPARE IT AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010104365A AR030740A2 (en) | 1996-05-21 | 2001-09-14 | A COMPOUND DERIVED FROM N-GLIOXYLPROLINE AND A METHOD TO PREPARE IT |
ARP010104364A AR030739A2 (en) | 1996-05-21 | 2001-09-14 | A NON-IMMUNOSUPRESSIVE COMPOUND DERIVED FROM N-GLIOXYLPROLINE, A METHOD TO PREPARE IT AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT |
Country Status (4)
Country | Link |
---|---|
AR (3) | AR004695A1 (en) |
ID (1) | ID16707A (en) |
TW (2) | TWI252226B (en) |
ZA (1) | ZA968983B (en) |
-
1996
- 1996-10-24 TW TW88118312A patent/TWI252226B/en not_active IP Right Cessation
- 1996-10-24 TW TW85113067A patent/TW453992B/en not_active IP Right Cessation
- 1996-10-25 ID IDP963062A patent/ID16707A/en unknown
- 1996-10-25 AR ARP960104916A patent/AR004695A1/en unknown
- 1996-10-25 ZA ZA968983A patent/ZA968983B/en unknown
-
2001
- 2001-09-14 AR ARP010104365A patent/AR030740A2/en unknown
- 2001-09-14 AR ARP010104364A patent/AR030739A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
TWI252226B (en) | 2006-04-01 |
ID16707A (en) | 1997-11-06 |
TW453992B (en) | 2001-09-11 |
ZA968983B (en) | 1998-07-27 |
AR030740A2 (en) | 2003-09-03 |
AR030739A2 (en) | 2003-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR036391A1 (en) | USE OF A PROSTAGLANDINE COMPOSITE TO PREPARE A PHARMACEUTICAL COMPOSITION TO OPEN CIC CHANNELS IN A MAMMER AND PROSTAGLANDINE COMPOUNDS | |
AR041303A1 (en) | N-SUBSTITUTED PIPERIDINIL-IMIDAZOPIRIDINE COMPOUNDS AS 5-HT4 "RECEIVER MODULATORS | |
NO20091704L (en) | Inhibitors of hepatitis C virus | |
EA200601830A1 (en) | ORT-SUBSTITUTED ARYL OR HETEROARYL AMIDAL COMPOUNDS | |
AR011882A1 (en) | DERIVATIVES OF N-OXIDES OF ESTERS, AMIDES, THIOESTERS AND HETERO CYCLIC KETONES, PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND. | |
ECSP066968A (en) | METHYL-ARIL OR HETEROARIL-AMIDA SUBSTITUTED COMPOUNDS | |
NO20062267L (en) | Hepatitis C virus inhibitors | |
CR5720A (en) | METHOD FOR USING NEUROTROPHIC SULFANAMID COMPOUNDS | |
AR011320A1 (en) | SULFONAMIDE COMPOUND LINKED WITH HETERO-CYCLIC THIOESTER N, PHARMACEUTICALLY ACCEPTABLE COMPOSITION, USE OF THE COMPOUND AND PROCESSES FOR LAPREPARATION OF THE COMPOUND | |
BRPI0518642A2 (en) | 12-aryl prostaglandin analogs | |
EA201101240A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA200100992A1 (en) | IMPDH ENZYME INHIBITORS | |
CO6331337A2 (en) | 5-SUBSTITUTED ISOINDOL COMPOUNDS | |
PE20130281A1 (en) | DERIVATIVES OF 5-ALKINYL-3-AMIDE-2-THIOPHENE-CARBOXYL ACID AS INHIBITORS OF FLAVIVIRIDAE VIRUS | |
EA201070782A1 (en) | OXADIAZOLE DERIVATIVES, ACTIVE WITH RESPECT TO Sphinhosin-1-phosphate (SIP) | |
RS51743B (en) | Macrocyclic inhibitors of hepatitis c virus | |
ECSP099269A (en) | FENILUREA COMPOUNDS AS SOLUBLE HYDROLASE EPOXIDE INHIBITORS | |
NO20091706L (en) | Inhibitors of hepatitis C virus | |
AR118724A1 (en) | DIHYDROOROTATE DEHYDROGENASE INHIBITORS | |
DK1313721T3 (en) | Non-imidazole aryloxyalkylamines as H3 receptor ligands | |
HK1051712A1 (en) | Acidic treatment liquid and method of treating copper surfaces. | |
PE20071225A1 (en) | PIPERIDINE-DERIVED COMPOUNDS AS INHIBITORS OF NEUROCININ-1 (NK-1) AND OF THE SEROTONIN TRANSPORTER | |
CO6321159A2 (en) | USED FUSIONED PIRAZINE COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
TNSN07439A1 (en) | Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics | |
AR004695A1 (en) | NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |